kls-13019
Generic: linoneyldihydroxybenzyl ethoxycarbonyl azetidine·Code: KLS-13019
kls-13019: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| NEUROPATHIX, INC. (TYGS) | Preclinical |
Get deeper analysis on kls-13019
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis